Ameriprise Financial Inc. lessened its holdings in CME Group Inc (NASDAQ:CME) by 11.9% during the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 2,477,130 shares of the financial services provider’s stock after selling 334,782 shares during the period. Ameriprise Financial Inc. owned about 0.73% of CME Group worth $336,090,000 at the end of the most recent quarter.
Several other hedge funds have also recently made changes to their positions in the company. Fiduciary Trust Co. acquired a new position in shares of CME Group in the second quarter worth approximately $105,000. Quadrant Capital Group LLC lifted its stake in shares of CME Group by 13.6% in the second quarter. Quadrant Capital Group LLC now owns 944 shares of the financial services provider’s stock worth $111,000 after acquiring an additional 113 shares during the period. San Francisco Sentry Investment Group CA acquired a new position in shares of CME Group in the second quarter worth approximately $129,000. Whittier Trust Co. lifted its stake in shares of CME Group by 2.6% in the second quarter. Whittier Trust Co. now owns 1,057 shares of the financial services provider’s stock worth $133,000 after acquiring an additional 27 shares during the period. Finally, People s United Financial Inc. lifted its stake in shares of CME Group by 11.5% in the second quarter. People s United Financial Inc. now owns 1,063 shares of the financial services provider’s stock worth $133,000 after acquiring an additional 110 shares during the period. 83.17% of the stock is currently owned by hedge funds and other institutional investors.
A number of equities analysts recently commented on the company. BidaskClub raised CME Group from a “hold” rating to a “buy” rating in a research note on Wednesday. Citigroup boosted their price target on CME Group from $138.00 to $155.00 and gave the company a “buy” rating in a research note on Thursday, October 19th. Royal Bank Of Canada boosted their price target on CME Group from $135.00 to $147.00 and gave the company an “outperform” rating in a research note on Monday, October 16th. Barclays boosted their price target on CME Group from $139.00 to $149.00 and gave the company an “overweight” rating in a research note on Tuesday, October 10th. Finally, Wells Fargo & Company boosted their price target on CME Group from $130.00 to $145.00 and gave the company a “market perform” rating in a research note on Wednesday, October 4th. One analyst has rated the stock with a sell rating, three have issued a hold rating and eight have issued a buy rating to the company’s stock. The company has an average rating of “Buy” and an average price target of $141.75.
CME Group Inc (NASDAQ CME) traded down $0.68 during midday trading on Thursday, hitting $152.07. The stock had a trading volume of 1,489,570 shares, compared to its average volume of 1,372,990. The company has a market capitalization of $51,750.00, a P/E ratio of 31.82, a price-to-earnings-growth ratio of 3.12 and a beta of 0.73. CME Group Inc has a 52-week low of $113.27 and a 52-week high of $155.29. The company has a debt-to-equity ratio of 0.11, a quick ratio of 1.05 and a current ratio of 1.05.
CME Group (NASDAQ:CME) last released its quarterly earnings data on Thursday, October 26th. The financial services provider reported $1.19 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $1.16 by $0.03. CME Group had a return on equity of 7.89% and a net margin of 40.94%. The firm had revenue of $890.80 million during the quarter, compared to the consensus estimate of $890.22 million. During the same quarter in the previous year, the company posted $1.05 earnings per share. The company’s quarterly revenue was up 5.8% on a year-over-year basis. equities analysts expect that CME Group Inc will post 4.78 EPS for the current year.
The business also recently declared a quarterly dividend, which will be paid on Wednesday, December 27th. Investors of record on Friday, December 8th will be issued a dividend of $0.66 per share. The ex-dividend date of this dividend is Thursday, December 7th. This represents a $2.64 annualized dividend and a yield of 1.74%. CME Group’s dividend payout ratio (DPR) is currently 59.86%.
In other CME Group news, insider Hilda Harris Piell sold 1,350 shares of the company’s stock in a transaction on Thursday, October 5th. The stock was sold at an average price of $138.00, for a total value of $186,300.00. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Dennis Suskind sold 750 shares of the company’s stock in a transaction on Monday, September 11th. The shares were sold at an average price of $129.34, for a total value of $97,005.00. Following the completion of the transaction, the director now owns 5,059 shares of the company’s stock, valued at approximately $654,331.06. The disclosure for this sale can be found here. Insiders have sold 34,921 shares of company stock valued at $5,016,248 in the last quarter. 0.57% of the stock is currently owned by corporate insiders.
COPYRIGHT VIOLATION WARNING: This piece was reported by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are reading this piece on another domain, it was illegally copied and republished in violation of US and international copyright and trademark legislation. The correct version of this piece can be read at https://www.dispatchtribunal.com/2017/12/07/ameriprise-financial-inc-trims-stake-in-cme-group-inc-cme.html.
CME Group Company Profile
CME Group Inc, through its exchanges, provides products across all asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural products and metals. The Company’s segment primarily consists of the Chicago Mercantile Exchange Inc (CME), Board of Trade of the City of Chicago, Inc (CBOT), New York Mercantile Exchange, Inc (NYMEX) and Commodity Exchange, Inc (COMEX) exchanges.
Receive News & Ratings for CME Group Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group Inc and related companies with MarketBeat.com's FREE daily email newsletter.